Form 424B5 Pyxis Oncology, Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq ends down as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
Pyxis Oncology terminates $150M ATM stock offering program
September 29, 2026 4:24 PM EDTPyxis Oncology (NASDAQ: PYXS) has terminated a continuous at-the-market stock offering program that had been set up to raise up to $150 million, according to a filing with the Securities and Exchange Commission.
The company had entered into a Sales Agreement with Leerink... More



